Vidac Pharma reports executive transactions under MAR Article 19
Vidac Pharma Holding PLC disclosed executive transactions under Article 19 of the Market Abuse Regulation. The report names Sandra Gamzon.
Related stories
Alphabet Convertible Preferred Yield Tops 7.5%
Alphabet’s mandatory convertible preferred stock, issued as part of its $85 billion equity capital-raising plan in June, has fallen alongside the company’s common stock and now yie
H impact | EQUITY | Oct 30, 2026, 07:25 PM UTC
JioStar Q2 Profit Falls 13% Amid Weak Advertising Environment
Reliance Industries' entertainment subsidiary reported September-quarter revenue up 10% year on year to Rs. 6,806 crore and EBITDA down nearly 14% to Rs. 1,502 crore. Profit after
M impact | EQUITY | Oct 30, 2026, 07:18 PM UTC
Nasdaq Near Session Lows Approaching Close
The Nasdaq remained near session lows approaching the close.
M impact | EQUITY | Oct 30, 2026, 07:16 PM UTC
Eli Lilly and AbbVie shares hit records after earnings and outlook increases
Shares of Eli Lilly and AbbVie reached new highs Friday after both companies reported stronger-than-expected third-quarter earnings and raised their full-year 2026 outlooks. Lilly
H impact | EQUITY | Oct 30, 2026, 07:14 PM UTC
First Industrial Realty Trust Shares Fall 1.2% After JPMorgan Downgrade
First Industrial Realty Trust shares were down 1.2% after JPMorgan downgraded the stock.
M impact | EQUITY | Oct 30, 2026, 07:13 PM UTC
Reddit Shares Fall 28.1% to $93.18 as Search Traffic Weighs
Reddit shares were down 28.1% at $93.18 at 11:30 a.m. ET on October 30 as investors weighed weaker search traffic and planned login tests.
M impact | EQUITY | Oct 30, 2026, 07:11 PM UTC